| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,656 |
10,523 |
$654K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,398 |
2,083 |
$159K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,415 |
2,132 |
$125K |
| 11721 |
|
10,247 |
8,347 |
$79K |
| 11056 |
|
9,279 |
7,574 |
$71K |
| 99243 |
|
572 |
527 |
$57K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,830 |
2,885 |
$38K |
| 73630 |
|
1,962 |
1,411 |
$17K |
| 29540 |
|
1,224 |
928 |
$15K |
| J3490 |
Unclassified drugs |
996 |
810 |
$9K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,087 |
875 |
$6K |
| 11730 |
|
157 |
128 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,068 |
867 |
$3K |
| 11055 |
|
481 |
380 |
$3K |
| 11755 |
|
28 |
25 |
$1K |
| 20550 |
|
37 |
27 |
$1K |
| 20600 |
|
40 |
36 |
$995.78 |
| 11720 |
|
16 |
13 |
$77.25 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
132 |
121 |
$0.00 |